Histologic, electron microscopic, and immunohistochemical studies were made to analyze the structural features and the cellular composition of the pulmonary lesions produced in rats by the administration of interleukin-2 (IL-2). This agent induced pulmonary edema; thickening of alveolar septa; damage to endothelial cells in capillaries and venules, marked interstitial infiltration by cytotoxic T lymphocytes, lymphokineactivated killer (LAK) cells, macrophages, and dendritic cells (as demonstrated by cell counting in preparations stained immunohistochemically with peroxidase-and fluorochrome-labeled antibodies); and injury to bronchiolar and alveolar epithelial cells. Granular and agranular lymphocytes often were closely apposed to endothelial cells in capillaries and venules. Contacts between lymphocytes and type II alveolar epithelial cells also were observed. Damaged type II alveolar epithelial cells showed nuclear and cytoplasmic features that are considered indicative of apoptosis (confirmed by nick end labeling). Phagocytosis of apoptotic bodies by macrophages was occasionally found. These results support the concept that IL-2 induces cytotoxic vascular and parenchymal cell damage that is mediated by LAK cells and cytotoxic T lymphocytes, which make contacts with endothelial cells and type II alveolar epithelial cells. This damage appears to be exacerbated by the secondary release of a variety of vasoactive agents and inflammatory mediators.
INTRODUCTION
Pulmonary edema is the most important manifestation of the vascular leak syndrome that develops as a complication from the use of interleukin-2 (IL-2) for the therapy of neoplastic disorders (6, 36) . The pulmonary morphologic alterations that occur in patients (25) and experimental animals (1, 11, 15, 33) treated with IL-2 consist of endothelial cell damage, interstitial edema, alveolar septal thickening, and exudation of plasma proteins into the extravascular compartment and alveolar lumina.
These changes are associated with extensive infiltration of lymphocytes and macrophages and, to a lesser extent, of eosinophils and neutrophils into the pulmonary interstitium. The pathogenesis of these changes is poorly understood, although considerable evidence (15) suggests that they are related to the infiltration of lymphokine-activated killer (LAK) cells into the lung. However, the lymphocyte populations infiltrating the lungs after administration of IL-2 have not been evaluated quantitatively or characterized phenotypically.
We have recently developed an animal model system, utilizing rats, for the study of the toxicity of IL-2, and we have analyzed in detail the resulting myocardial lesions (44) . In the present study, we have employed this model of IL-2 toxicity to study: (a) the structural alterations in the endothelial and epithelial cells of the lung and (b) changes in the pulmonary immune effector cells.
MATERIALS AND METHODS
Animals. Sixteen female Sprague-Dawley rats, weighing 180-200 g, were divided into 4 groups (each, n = 4). Three daily doses of 5 x 105 Cetus units of IL-2 (kindly provided by the Cetus Corporation, Emeryville, CA) were given intraperitoneally for 2, 3, and 5 days (Groups 1, 2, and 3), respectively. Control rats (group 4) were treated with TABLE 1. -antibodies used in the immunohistochemical studies and their reactivity with rat tissue components. a 1 = Wako Chemicals USA, Inc., Richmond, VA; 2 = Accurate Chemical & Scientific Corp., San Diego, CA; 3 = Harlan Bioproducts for Science, Inc., Indianapolis, IN. excipient. All rats were killed by intraperitoneal injection of pentobarbital 12 hr after the last IL-2 injection. All procedures in this study were approved by the Center for Drug Evaluation and Research Institutional Animal Care and Use Committee and followed the guidelines of NIH publication 8 S-23 (Use and Care of Laboratory Animals).
Histologic and Electron Microscopic Preparations. Portions of the major organs were removed, fixed with 10% formalin and embedded in paraffin, and sectioned and stained with hematoxylin and eosin. For electron microscopic study, the tissues were fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer, pH 7.2, postfixed with 1 % OsO, in 0.1 1 M phosphate buffer, pH 7.2, and embedded in polybed 812. One-Am-thick sections were cut, stained with alkaline Toluidine blue, and examined with a light microscope to select areas for ultrathin sectioning. Ultrathin sections were stained with uranyl acetate and lead citrate and examined with a transmission electron microscope.
Labeling of Apoptotic Cells. The nuclei of cells undergoing apoptosis were selectively stained using the ApopTag kit (ONCOR, Inc., Gaithersburg, MD) according to the manufacturer s instructions. In this nick end labeling method, digoxigenin-labeled dioxyuridine phosphate is enzymatically linked (by incubation with a terminal deoxynucleotide transferase) to the free 3-hydroxy groups of DNA that has been cleaved by endonucleases in cells undergoing apoptosis. The incorporated deoxyuridine residues are visualized by means of peroxidase-conjugated antidigoxigenin antibody and diaminobenzidine tetrahydrochloride/H~O~. Immunohistochemical Studies. The following antibodies were used for the immunohistochemical studies: (a) W3/25 antibody, which reacts with the rat equivalent of human CD4 and labels T-helper lymphocytes and some dendritic cells and macro-phages ; (b) OX8 antibody, which reacts with the rat equivalent of human CD8 and identifies cytotoxic/ suppressor T lymphocytes and some natural killer (NK) cells; (c) Anti-asialo GM, ganglioside antibody (herein referred to as AS-GM, antibody), which reacts with a subset of LAK cells and with some NK cells and CD8+ lymphocytes; (d) OX18 antibody, which reacts with major histocompatibility complex (MHC) class I antigens; (e) OX6 antibody, which reacts with MHC class II antigens (Ia antigens) and labels interstitial dendritic cells intensely but also labels B cells and some macrophages; (f) ED2 antibody, which reacts with tissue macrophages; and (g) W6/32 antibody, an irrelevant antibody that reacts with human HLA-A, HLA-B, and HLA-C antigens but not with rat tissue components. The immunological characteristics, the dilutions employed, and the commercial sources of these antibodies (1, 4, 10, 16, 21, 27, 30, 43) are listed in Table I . Detailed descriptions of the procedures involving the use of these peroxidase and fluorochrome-labeled antibodies have been presented previously (44, 46, 47) . Preparations stained by single or double immunofluorescence labeling methods were counterstained with DAPI (4',6-diamidino-2-phenylindole), 0.1 Ag/ml in phosphate-buffered (0.01 M, pH 7.4) saline for 15 min, to demonstrate nuclei. These preparations were examined with a Zeiss Photomicroscope II equipped with incident light optics and standard filters for ultraviolet (UV), blue, and green excitation. In addition, a triple bandpass filter (No. 61002, Chroma Technology, Battleboro, VT) was used for simultaneous visualization of the fluorescence of DAPI and of the fluorescein isothiocyanate-/and Texas red-labeled conjugated antibodies. Further examination of these preparations was performed using a Leica laser scanning confocal microscope equipped with argon and argon-krypton lasers for the scanning of images generated by UV, blue, and green excitations (corresponding to blue, green, and red fluorescence emissions).
Immunohistochemical Control Procedures. Sections of normal rat spleen were used as positive controls for the immunohistochemical staining. Two negative controls were used: (a) preparations in which incubation with the first (primary) antibody was omitted and (b) preparations incubated with the irrelevant antibody W6/32. Cell Counts. Using preparations appropriately stained with peroxidase-labeled antibodies, the numbers of T-helper lymphocytes (W3/25 antibody), cytotoxic T lymphocytes (OX8 antibody), AS-GM1 + cells, interstitial dendritic cells (OX6 antibody), and macrophages (ED2 antibody) were counted in 50 randomly selected fields (each measuring 200 by 210 Mm) using a digitizing tablet interfaced with a Zeiss Videoplan II system (Carl Zeiss, New York). Criteria employed for the identification of these types of cells have been presented previously (44, 46) . Bronchi and bronchial-associated lymphoid tissue were excluded from the areas of tissue used for counting. All cell counts are expressed as mean number ± SD of cells/mmz of tissue section. Differences in cell counts were evaluated using a 2-tailed Student T-test, with p s 0.05 taken as the level of significance.
RESULTS
The gross anatomic and histopathologic alterations in rats treated with IL-2 for 2, 3, and 5 days were similar to those described previously (47) . Focal necroses and infiltrates composed of lymphocytes, macrophages, and much smaller numbers of eosinophils and neutrophils were found in heart and liver. The lungs were edematous and congested, with focal hemorrhages. Accumulations of yellowish fluid were found in the pleural cavities. These changes were most severe after 5 days of treatment.
Histologic Observations
Control Animals. The lungs of control animals were histologically normal. The alveolar septa were thin, and the postcapillary venules had thin, flat endothelial cells ( Fig. la) . No lymphocytes or neutrophils were closely apposed to the endothelial cells of venules or capillaries. Lymphocytes and macrophages were occasionally present in the interstitium.
IL-2-Treated Animals. In rats given IL-2 for 2 days, the alveolar septa were slightly thickened (Fig.  1 b) and edematous and contained small numbers of lymphocytes and eosinophils. A mild lymphocytic infiltrate was present around venules. Some lymphocytes were in close contact with the endothelial surfaces of these venules. Mitotic figures were observed in some lymphocytes. No erythrocyte, fibrin, or proteinaceous exudates were found in the alveolar lumina. On day 3, moderate lymphocytic infiltration was present in the thickened alveolar septa and in the perivascular interstitium ( Fig. 1 c) . The lumina of venules often were occupied by numerous lymphocytes. Many of these lymphocytes were in close contact with the endothelial cells. Small, focal areas of intraalveolar hemorrhage were evident. On day 5, the alveolar septa were markedly thickened and contained numerous small and large lymphocytes, macrophages, and some eosinophils. The interstitium around pulmonary venules also contained numerous lymphocytes. Mitotic figures were prominent in some lymphocytes. The lumina of venules were enlarged and filled with lymphocytes, neutrophils, and macrophages ( Fig. 1 d) .
Electron Microscopic Observations
Control Animals. Electron microscopic study of control animals revealed normal pulmonary ultrastructure. The alveoli were lined by type I and type II epithelial cells. The latter were characterized by surface microvilli and by lamellar bodies, which consisted of electron-dense lamellae arranged concentrically or in parallel stacks. The alveolar septal capillaries were thin-walled, and their endothelial cells had typical intercellular junctions and moderate numbers of pinocytotic vesicles. Venules were composed of an endothelial cell layer and an investing layer that consisted of only a few discontinuously arranged smooth muscle cells and/or pericytes. This investing layer was poorly developed in postcapillary venules. Interstitial cells in alveolar septa consisted of small numbers of fibroblasts, myofibroblasts, smooth muscle cells, pericytes, dendritic cells, lymphocytes, and macrophages. IL-2-Treated Animals. The main ultrastructural changes produced by IL-2 in the lungs were (a) endothelial cell damage, (b) interactions between inflammatory cells and endothelial cells, (c) infiltration of both granular and agranular lymphocytes, (d) formation of clusters of lymphocytes and dendritic cells, and (e) damage to type II alveolar epithelial cells. Endothelial Cell Damage: In rats given IL-2 for 2 and 3 days, the endothelial cells in capillaries and venules contained increased numbers of pinocytotic vesicles and enlarged cisterns of smooth endoplasmic reticulum. In rats given IL-2 for 5 days, endothelial cells in these areas were edematous and contained concentric lamellae (myelin figures); the nuclei were large and protruded into the lumina.
Interactions days. The alveolar septa are slightly thickened. A mild lymphocytic infiltrate is present. x 630. c) Rat treated with IL-2 for 3 days. The lumen of a venule is occupied by lymphocytes and neutrophils. The alveolar septa are moderately thickened and infiltrated by lymphocytes and macrophages. x 630. d) Rat treated with IL-2 for 5 days. The alveolar septa are markedly thickened and contain numerous lymphocytes and macrophages. A venule is dilated and contains many mononuclear inflammatory cells. x 630. sinophils, neutrophils, and platelets. Some of these lymphocytes were tightly apposed to the surfaces of endothelial cells in capillaries ( Fig. 2) and venules ( Fig. 3 ). Many areas of contact between these cells were smooth and without interdigitations; however, some lymphocytes contacted the surfaces of the endothelial cells by means of cytoplasmic processes. Many small projections of endothelial cells interdigitated with small pseudopodia of these intraluminal lymphocytes (Fig. 2 ). Infiltration of Both Granular and Agranular Lymphocytes : Agranular lymphocytes and macrophages were the most common types of immune effector cells found in the alveolar septa. Small and mediumsized agranular lymphocytes predominated in the inflammatory infiltrate. Large agranular lymphocytes had prominent nucleoli and numerous ribosomes. Relatively few large granular lymphocytes were found, each possessing a small number of cytoplasmic granules, 0.1-0.3 Am in diameter (Fig. 4) . Lymphocytes were frequently found to be undergoing mitosis (Fig. 5 ). Both large granular and agranular lymphocytes were more frequent on day 5 than on days 2 and 3. Macrophages contained single, kidney-shaped nuclei and numerous lysosomes, some of which had a few concentric lamellae. Small numbers of eosinophils were also found.
Formation of Clusters of Lymphocytes and Dendritic Cells: Clusters of several agranular lymphocytes surrounding a dendritic cell were found in the interstitium. The dendritic cells were characterized by irregular or elongated shapes, with thin cytoplasmic processes; single nuclei, which occupied most of the cell volume; a few small cisterns of rough-surfaced endoplasmic reticulum; and a few cytoplasmic organelles. Dendritic cells lacked basement membranes and showed no evidence of phagocytic activity. Clusters of dendritic cells and agranular lymphocytes (Fig. 6 ) were more frequent on day 5 than on days 2 and 3. The lymphocytes contacting dendritic cells had somewhat elongated shapes, abundant cytoplasm, and larger nuclei. Both the cell bodies and the cytoplasmic processes of dendritic cells were in close contact with lymphocytes. Damage to Epithelial Cells: At all times studied, the bronchiolar ciliated cells had swollen mitochondria and dilated cisterns of rough-and smoothsurfaced endoplasmic reticulum. The Clara cells of bronchioles displayed many large, dilated cisterns of smooth endoplasmic reticulum in their apical regions. Type I alveolar epithelial cells showed swelling and decreased electron density of their cy-toplasm. Type II alveolar epithelial cells appeared to be injured and many of their lamellar bodies were mostly empty and electron-lucent, thus differing from those in control animals.
At 3 and 5 days, some type II alveolar epithelial cells had many large vacuoles, pyknotic nuclei, and lucent lamellar bodies. Remnants of necrotic type II alveolar cells were found in some alveolar spaces.
Lymphocytes formed close contacts with type II alveolar epithelial cells (Fig. 7) . These contacts involved the close approximation and interdigitation of the plasma membrane of the lymphocyte with that of the basal region of the epithelial cell. The epithelial basement membranes in such areas were often attenuated or focally absent. Discharged secretory material from the lamellar bodies of type II epithelial cells was occasionally found in the alveolar spaces.
The damaged type II alveolar epithelial cells (Fig.  8 ) were characterized by the following features: (a) decreased nuclear size, (b) increased density and clumping of the nuclear chromatin, (c) increased density of the cytoplasm, (d) loss of the microvilli normally present on the luminal surface, and (e) partial or complete loss of the content of the lamellar bodies. In addition, macrophages containing phagocytosed apoptotic bodies were also observed in the alveolar lumina ( Fig. 9 ).
Labeling of Apoptotic Cells
Sections in which apoptotic cells were labeled using the ApopTag method showed a positive reaction in the nuclei of a few type II alveolar epithelial cells in the lungs of rats treated with IL-2 for 3 and 5 days. The reactive nuclei were small, irregularly shaped, and intensely reactive (Fig. l0a ). Other types of cells were not stained by this method.
Immunohistochemical Study
Immunohistochemical studies served to identify the various types of immune effector cells infiltrating the lungs. The study also demonstrated that the -FIG. 6.-Rat treated with IL-2 for 3 days. A cell cluster is composed of several agranular lymphocytes in close apposition to a cell with the morphological characteristics of a dendritic cell. This cell is elongated and has several cytoplasmic processes (arrows), and most of its volume is occupied by the nucleus. x 4,500. FIG. 7. -Rat treated with IL-2 for 5 days. Two agranular lymphocytes are closely apposed to a type II alveolar epithelial cell. One of these contacts involves interdigitations of the plasma membranes of the 2 cells. The epithelial basement membrane in this area of contact is focally discontinuous (arrowhead). The apposed membranes in the other area of intercellular contact are smooth. x 6,700. 10. -a) The nuclei of 2 type II alveolar epithelial cells undergoing apoptosis are identified (dark brown staining) in section of lung of rat treated with IL-2 for 5 days. The preparation was stained according to the nick end labeling method and was viewed with Nomarski differential interference contrast optics. x 400. b-d) Fluorescence micrographs of lung tissue from rats treated with IL-2 for 3 days. Sections were stained with various antibodies for the identification TABLE IL-Counts of immune effector cells in lungs of rats given 3 daily doses of 5 x 105 Cetus units of IL-2.a &dquo; all data are expressed as the number of cells ± SD/MM2 of tissue section.
b Significantly different when compared to the group given saline (p < 0.05). c Significantly different when compared to the group given IL-2 for 5 days (p < 0.05). numbers of all these types of cells were small in control tissues but increased progressively from day 2 to day 5.
W3/25 Antibody. T-helper lymphocytes, macrophages, and many dendritic cells gave a positive reaction for W3/25 antibody. Lymphocytes forming clusters with dendritic cells usually gave a positive reaction with the W3/25 antibody. OX8 Antibody. In control tissues, OX8+ cells were scattered in the alveolar septa and perivascular interstitium. In rats treated with IL-2, OX8+ cells were diffusely distributed throughout the thickened alveolar septa and the perivascular interstitium ( AS-GM, Antibody. Reactive cells showed only surface staining, most often limited to certain regions of the surface (Fig. 1 Oc). This pattern of staining was best demonstrated by confocal microscopy (Fig.  lOd) . The reactive cell were distributed and were distributed in the alveolar septa, the perivascular, and peribronchial interstitium and in the bronchialassociated lymphoid tissues. On day 2, increased numbers of reactive cells were found in thickened alveolar septa. After 3 and 5 days, these cells were present in greater numbers in the septa and the perivascular interstitium but predominated in the latter. Some cells were either tightly apposed to the endothelial cells of venules or were present within the walls of the venules.
OXl8 Antibody. In control animals, the surfaces of endothelial cells and type II alveolar epithelial cells were either negative or weakly stained. A consistently positive reaction was found only in dendritic cells and lymphocytes. In rats treated with IL-2, OX 18 antibody labeled the surfaces of the type II alveolar epithelial cells and the endothelial cells of venules more intensely than in control animals. The intensity of this labeling increased with the dose of IL-2.
OX6 Antibody. After staining with OX6 antibody, only a few reactive dendritic cells, B lymphocytes, and macrophages were found in control tissues. The dendritic cells were localized in the alveolar and perivascular interstitium and within the epithelial cell layer in bronchi and bronchioles. These observations are similar to those reported by Gong et al (17) and Holt et al (19) . In animals treated with IL-2, dendritic cells increased in number in all the locations just cited (Fig. lOc) . In severely thickened alveolar septa, the dendritic cells were enlarged and more irregular in shape. OX6 antibody-positive B lymphocytes and macrophages were found in the perivascular interstitium, the alveolar septa, and subpleura areas. Macrophages were distinguished from B lymphocytes on the basis of their much larger size. ED2 Antibody. Labeling with ED2 antibody was limited to macrophages. This labeling was intense and distributed throughout the cytoplasm.
Immunohistochemical Control Procedures
No reaction was observed in any of the preparations stained with the irrelevant antibody W6/32. Similarly, no staining was observed in control preparations in which incubation with the first antibody had been omitted.
Counts of Immune Effector Cells
W3/25, OX8, AS-GM¡, OX6, and ED2 antibodies were used for the counts of immune effector cells.
The results of these counts are presented in Table  II . As compared to control animals, IL-2-treated animals showed large increases in the numbers of of immune effector cells. b) OX8 antibody/FITC. There is marked infiltration by cytotoxic T lymphocytes. x 630. c) AS-GM, antibody/Texas red; OX6 antibody/FITC; DAPI nuclear stain. Photograph taken with triple bandpass filter system shows green fluorescence of OX6 ~ macrophages and dendritic cells, red fluorescence of AS-GM¡-LAK cells, and blue fluorescence of all nuclei. x 400. d) AS-GM, antibody/Texas red; DAPI nuclear stain. Photograph taken with laser scanning confocal microscope shows discontinuous surface staining (red fluorescence) in large cells, presumed to be LAK cells. Nuclei show blue fluorescence. x 630. cytotoxic T cells, LAK cells, macrophages, and dendritic cells; only small increases were found in T-helper cells. After IL-2 treatment, the numbers of these cells were significantly greater on day 5 than on days 2 and 3.
DISCUSSION

Pathogenesis of IL-2-Induced Pulmonary Toxicity
Multiple factors appear to be involved in the pathogenesis of the pulmonary alterations induced by IL-2. As discussed in detail later, the administration of this agent has been shown to result in the activation of endothelial cells and lymphocytes. This leads to (a) an upregulation of cell adhesion molecules ; (b) an increased adherence of lymphocytes, other types of leukocytes, and platelets to the endothelial cells, particularly in postcapillary venules; and (c) increased transvascular migration of these cells. The activation of leukocytes and endothelial cells and the subsequent interactions among these cells result in the release of many agents including tumor necrosis factor (TNF) (18), interleukin-1 (29), interferon-v (18), oxygen free radicals (29) , thromboxane (23) , and platelet-activating factor (34) and in the activation of the complement system (26) . All of these substances are capable of inducing a large variety of toxic effects.
Alterations in Endothelial Cells and Enhanced
Expression of MHC Class I Antigens
The microvascular alterations found in the present study constitute important determinants of the vascular leak produced by IL-2. We consider that the increased numbers of pinocytotic vesicles that we observed in endothelial cells are indicative of increased fluid transport. However, we attribute the intracellular edema and the myelin figures to cell damage. We regard the nuclear enlargement as evidence of activation of the endothelial cells. Endothelial structural changes often coexisted with the apposition of granular and agranular lymphocytes, neutrophils, eosinophils, macrophages, and platelets to the surfaces of the endothelial cells and with evidence of passage of these cells into the perivascular interstitium. Similar findings have been demonstrated in rat myocardium after the administration of IL-2 (47) . The activation of endothelial cells by IL-2 is associated with the expression of 3 activation antigens: endothelial-leukocyte adhesion molecule I, intercellular adhesion molecule 1, and human leukocyte antigen DQ (8) . The finding that IL-2 itself does not induce an increase in the permeability of endothelium in vitro (23) suggests that IL-2 causes alterations in pulmonary microvascular permeability only by indirect mechanisms. IL-2 enhances the adhesion of LAK cells, which can damage and lyse endothelium (2, 9, 11) and of other types of leukocytes, which can exert various other cytotoxic effects. Furthermore, it has been suggested that MHC class I antigens also function as cell adhesion molecules in many cell-to-cell interactions (12) . We believe that the enhanced expression of MHC class I antigens (as shown by immunohistochemical staining with OX 18 antibody) by the endothelial cells may facilitate their interaction with cytotoxic T lymphocytes and LAK cells, thus contributing to the pulmonary vascular damage (14) .
Damage to Pulmonary Alveolar Epithelial Cells
The alterations found in the present study in type I alveolar epithelial cells are similar to those previously observed in IL-2-induced pulmonary toxicity and appear to represent nonspecific manifestations of cell injury (1, 15, 33) . However, damage to type II cells by IL-2 has not been previously described. Such damage is of importance because these cells constitute the source of renewal of both type I and type II alveolar epithelium (22) . The contacts between lymphocytes and type II alveolar epithelial cells are of special interest. Such contacts, which have not been described previously, suggest that lymphocytes can exert direct cytotoxic effects on type II alveolar epithelial cells. This type of damage appears to be similar in some respects to that observed in cardiac myocytes of rats treated with IL-2. In these animals, we found close contacts between lymphocytes and myocytes, often in coexistence with nuclear and cytoplasmic damage to the latter cells. Considerable evidence supports the concept that this type of damage results from the release of perforin, granzyme A, lysosomal hydrolytic enzymes, and other toxic substances from the lymphocytes in association with their forming contact with target cells [see Zhang et al (47) for review]. The contacts between lymphocytes and type II alveolar epithelial cells may have been facilitated by 2 factors: (a) the enhanced expression of MHC class I antigens that we observed in type II cells and (b) the fact that the basement membranes of type II cells normally have discontinuities through which short cytoplasmic processes extend into the subjacent interstitium. These processes normally form direct contacts with interstitial fibroblasts and myofibroblasts (23) . Such areas, in which the protective barrier function of the epithelial basement membrane is absent, are not found in type I alveolar epithelial cells. It has not been determined whether similar contacts occur in other conditions in which lymphocytic infiltration of the pulmonary parenchyma is associated with alveolar epithelial damage.
The morphological features of the damage that we observed in type II alveolar epithelial cells correspond to those of apoptosis (7) (i.e., nuclear and cytoplasmic condensation, chromatin clumping, cell shrinkage, and eventual formation ofapoptotic bodies). Apoptotic bodies appeared to be phagocytosed by macrophages present in the alveolar lumina. We are not aware of previous reports of apoptosis de- veloping in type II alveolar epithelial cells. In fact, Wendt et al (42) showed that type II alveolar epithelial cells secrete a material that inhibits the induction of apoptosis by TNF-a in pulmonary endothelial cells. In the present study, we did not observe morphologic evidence of apoptosis in endothelial cells. Using the nick end labeling method, we were able to demonstrate fragmentation of nuclear DNA in some type II alveolar epithelial cells but not in other types of pulmonary cells. Although this finding confirms the occurrence of apoptosis in type II alveolar epithelial cells, the significance of this observation remains to be assessed in detail. Other studies have demonstrated the importance of apoptosis in the killing of various types of neoplastic cells as the result of the cytotoxic effects of various chemotherapeutic agents (7) and in the pulmonary structural remodeling that follows the intraalveolar migration of interstitial myofibroblasts (intraalveolar budding) (31).
Granular and Agranular Lymphocytes
Both granular and agranular lymphocytes were frequently apposed to endothelial cells in pulmonary venules and capillaries. It has been generally accepted that LAK cells include not only NK cells but also activated, non-MHC requiring T-cells (39) . NK cells have been operationally defined as large granular lymphocytes that mediate cytolytic reactions even in the absence of expression of MHC class I or class II antigens on the target cells. However, large granular lymphocytes correspond morphologically not only to NK cells, but also to some resting T cells and activated cytotoxic T lymphocytes (39) .
We believe that most of the large granular lymphocytes identified in the present study corresponded to AS-GM1+ LAK cells. There is clear evidence that cytotoxic lymphocytes also are involved in the pathogenesis of IL-2-induced lung injury. A pronounced infiltration of cytotoxic lymphocytes has been found in IL-2-treated patients (5) . These changes are similar to those found in the present study. The numbers of cytotoxic lymphocytes in lung tissue increased markedly after the administration of IL-2, from a control value of 9.5 ± 0.5 cells/mm2 to 109 ± 28, 125 ± 36, and 198 ± 37 cells/mm-' after 2, 3, and 5 days of treatment, respectively.
Dendritic Cells
Pulmonary dendritic cells play an important role in the regulation of cell-mediated cytotoxicity and modulate lymphocyte proliferation (24) . The numbers of dendritic cells were greatly increased, from a value of 2 ± 0.5 cells/mm2 of tissue section in control animals to 7 ± 2, 22 ± 7, and 69 ± 27 cells/ mm2 after 2, 3, and 5 days of treatment with IL-2, respectively. These increases were considered to result from recruitment of dendritic cells to lung tissue, as these cells are known to originate in bone marrow, from which they migrate through the bloodstream (3). It seems likely that the increased numbers of dendritic cells observed in this study induce the local proliferation of lymphocytes, as evidenced by the occurrence of mitotic figures in the latter cells.
The present study also revealed that clusters of dendritic cells and T-helper cells form in the lung after the administration of IL-2. The interaction between dendritic cells and resting T cells first induces proliferation of helper-T and, in turn, proliferation of cytotoxic T lymphocytes (20) . These clusters provide opportunities for interactions between the 2 types of cells that they contain. Helper-T cells in clusters of this type release lymphokines, including IL-2, which function in the induction of cytotoxic lymphocytes (20) . Even in the absence of T-helper cells, dendritic cells can directly stimulate cytotoxic lymphocytes to proliferate and to become killer cells (20) . Thus, the clusters of dendritic cells and T cells may contribute to the toxicity induced by the administration of IL-2.
Inflammatory Cells and Release of Cytokines
The morphological findings and the results of the cell counts in the present study demonstrate that AS-GM, + LAK cells and cytotoxic lymphocytes are the predominant phenotypes of the lymphocytic infiltrates that develop in the lungs after treatment with IL-2. B lymphocytes were present in very small numbers and did not represent quantitatively significant components of these infiltrates. In addition to their direct interactions with endothelial cells and lymphocytes, the increased numbers of macrophages found in the present study may have participated in the pathogenesis of the vascular leak by producing IL-1 and TNF. Alveolar macrophages are capable of synthesizing TNF in response to IL-2 (38) . In our study, macrophages increased in numbers from a control value of 17 ± 1 cells/mm2 of tissue section to 42 ± 12, 62 ± 20, and 106 ± 12 cells/mm2 after 2, 3, and 5 days of treatment, respectively. TNF is an important mediator of acute lung injury (37) . IL-2 induces the formation of increased amounts of TNF and IL-1. These agents can directly alter endothelial permeability (28) and can induce a vascular leak syndrome, with adhesion of neutrophils to endothelium and extravasation of plasma proteins, inflammatory cells, and platelets (45) . Furthermore, IL-2 has been shown to induce the formation and release of interleukin-5, which leads to marked peripheral eosinophilia and degranulation of eosinophils (40) . The release of toxic products from eosinophils also may contribute to the pathogenesis of the vascular leak syndrome (40) . In addition, IL-2 has been demonstrated to induce platelet and neutrophil-endothelial adherence (13) and to activate neutrophils by inducing the release of thromboxane B2 (41 ) . Our previous study (46) and the present study showed evidence of the adhesion of neutrophils and platelets to endothelium and the extravasation of these cells. Therefore, these findings point to the role of neutrophils and platelets in the vascular damage produced by IL-2.
CONCLUSIONS
The present study provides a characterization of the pulmonary structural and immunological changes produced by the administration of IL-2.
The structural alterations involved the microvasculature and the alveolar walls. Both the endothelial cells of venules and capillaries and the type II alveolar epithelial cells formed close contacts with lymphocytes, and such contacts appeared to result in cytotoxic effects. The features of the damage induced in type II alveolar epithelial cells corresponded to those of apoptosis. The numbers of cytotoxic T lymphocytes, LAK cells, macrophages, and interstitial dendritic cells were greatly increased in the lungs, and evidence of local proliferation of lymphocytes was also observed. These results support the concept that activation of endothelial cells and lymphocytes by IL-2 is the initial event that leads to pulmonary structural damage in IL-2 toxicity.
